Tuesday, 20 September 2022

Juul sues FDA for documents said to justify e-cigarette ban

Juul sues FDA for documents said to justify e-cigarette ban

Juul Labs has sued the U.S. Food and Drug Administration over the agency's refusal to disclose documents supporting its order banning the company, which has been blamed for fueling a teenage vaping crisis, from selling e-cigarettes on the U.S. market.

Canada to drop COVID vaccine requirement for entering country on Sept 30 - Globe and Mail

Canada's federal government plans by Sept. 30 to drop the COVID-19 vaccine requirement for people who enter Canada, The Globe and Mail reported on Tuesday, citing sources.

CVS, Walmart reach $147.5 mln opioid settlement with West Virginia -attorney general

CVS Health Corp and Walmart Inc have agreed to pay $147.5 million to settle West Virginia's claims over their alleged roles in the state's opioid crisis, state attorney general Patrick Morrisey said Tuesday.

U.S. delivers over 25 mln COVID boosters; Moderna's shot in limited supply

The United States government has sent out over 25 million of the updated COVID-19 booster shots, mostly from Pfizer /BioNTech , as production of the Moderna shot continues to ramp up, a federal health agency said on Tuesday.

France clears Omicron-adapted COVID boosters for autumn vaccination drive

France's HAS health authority on Tuesday followed the European Union's drug regulator and cleared two separate COVID-19 vaccine boosters updated to target the Omicron variant.

Newsletter H236 x W452.png
Sponsored by Roche: Where you live should not determine if you live

Our panel, featuring Apl.De.AP, Dr Ratna Devi and Muniba Mazari engaged in a lively discussion on improving access to healthcare in Asia

Watch our LifeTalk now!

EU health regulator says COVID pandemic not over

An official at the European Union's drugs regulator said on Tuesday the COVID-19 pandemic was not over, contradicting U.S. President Joe Biden, and that a planned vaccination campaign in the region during the cold season was key to fighting it.

U.S. FDA staff raises concerns on Spectrum Pharma's cancer drug

The U.S. Food and Drug Administration's (FDA) staff on Tuesday raised concerns over the safety of Spectrum Pharmaceutical's experimental cancer drug and questioned the benefits it provided over existing therapies, dragging its shares 30%.

Illumina's Grail expands use of cancer detection test with life insurer deal

Cancer detection test maker Grail, acquired by Illumina Inc last year despite ongoing antitrust challenges, on Tuesday said it would expand use of its flagship Galleri test through a new agreement with life insurer John Hancock, a division of Manulife Financial .

Deadly childhood diseases rise in Ethiopia's Tigray as war hampers vaccinations

Deadly diseases such as measles, tetanus and whooping cough are on the rise in Ethiopia's Tigray region after vaccination rates plunged during the civil war that broke out nearly two years ago, doctors and regional health officials say.

Merck to start studying lower dose of HIV drug after FDA hold

Merck & Co Inc said on Tuesday it would start fresh late-stage studies of its HIV treatment, islatravir, months after the U.S. Food and Drug Administration put the trials on hold, citing safety concerns.

Related Videos

End of COVID pandemic is 'in sight' -WHO chief

Millions locked-down in Shenzen over COVID fears

FDA approves Omicron-targeting booster shots